Singapore: Boehringer Ingelheim has invested around $94 million to fund the expansion of its manufacturing plant in Chin...
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...
Singapore: China is undergoing major healthcare reform and the bio and pharmaceutical market is expected to maintain dou...
Singapore: The police in China have made it official that four senior Chinese executives of GlaxoSmithKline have been de...
Singapore: The Tomato Genome Consortium (TGC), which is a group of over 300 scientists from 13 countries sequenced the g...
Singapore: China Biologic Products, a leading fully integrated plasma-based biopharmaceutical company in China, will rel...
Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule...
Singapore: Charles River Laboratories is soon to acquire CRO services division of Galapagos, which includes both Argenta...
Bangalore: GE Healthcare, and BGI, the world's largest genomics organization, have entered into a pioneering multi-year ...
Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, ...
Singapore: Temptime, the world leader in time temperature indicators, has opened a business office in Beijing, China, ma...
Singapore: US-based United Parcel Service (UPS) has expanded its global healthcare distribution facility network in the ...
Singapore: Bristol-Myers Squibb (BMS) has entered into a multi-year strategic partnership with Tsinghua University, Beij...
Singapore: LanzaTech appointed Mr Ken C Lai as VP of its Asia Pacific operations. Based in Shanghai, he will oversee the...
Singapore: Chinese prosecutors have received more than 600,000 inquiries about bribery records involving companies or in...
Singapore: After a series of long drawn investigations that led to scandalous allegations and even more scandalous confe...
Singapore: Even as police in China are investigating claims of bribery against the British drug major for bribing doctor...
Government policies are among the major challenges before companies operating in the life sciences sector in the Asia Pa...
